SLC6A3 and Parkinsonism: Another PET study (11) with a dopamine transporter radioligand 11C-DTBZ used for the assessment of Parkinson’s found that 22q11.2 DS individuals presented a reduction in the striatal signal as expected in individuals with Parkinson’s disease (69).